| CPC A61K 9/167 (2013.01) [A61K 33/04 (2013.01); A61K 33/24 (2013.01); A61L 27/025 (2013.01); A61L 27/306 (2013.01); A61L 31/088 (2013.01); A61L 2300/10 (2013.01); A61L 2300/608 (2013.01); A61L 2420/08 (2013.01)] | 12 Claims |

|
1. A material composition suitable for use as a bioactivatable coating for an implantable medical device, said composition comprising one or more transition metal chalcogenides provided in a non-bioactive form that are converted into a charged bioactive form upon exposure to physiological conditions, wherein said one or more transition metal chalcogenides are defined by Formula I:
MxAyBz (Formula I)
having an index number x, y, and z that each constitute a non-zero atomic ratio of the material composition in which:
M is a transition metal element, further wherein M is molybdenum present in an atomic ratio x is 1 or 3;
A is a first chalcogenide element, further wherein A is sulfur present in an atomic ratio y, which is greater than 0 and less than or equal to 9;
B is a second chalcogenide element selected from the group consisting of oxygen and selenium, further wherein B is present in an atomic ratio z, which is greater than 0 and less than or equal to 9; and
wherein a sum of the atomic ratios y and z of the first and second chalcogenide elements A and B is non-stoichiometric and differs in a range from 0.01 to 20% from a corresponding stoichiometric sum that is sum defined as 2, 3, or 9, and wherein further, the material composition includes titanium, wherein an atomic ratio of Ti:M is in the range of 0.01 to 20%.
|